Marketing-authorisation holder · United States
Tolmar
4 medicines in 1 country, as authorisation holder.
Group structure
Part of
TolmarPharmaceutical groupOther companies in the group
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ELIGARD KIT22.5mg | 30mg | 45mg | 7.5mg · Powder | Leuprorelin | United States | Marketed | 2002 |
| FENSOLVI KIT45mg · Powder | Leuprorelin | United States | Marketed | 2020 |
| JATENZO158mg | 198mg | 237mg · Capsule | Testosterone | United States | Marketed | 2019 |
| PALIPERIDONE PALMITATE117mg/0.75ml | 156mg/ml | 234mg/1.5ml | 39mg/0.25ml | 78mg/0.5ml · Suspension, extended release | Paliperidone | United States | tentative | 2023 |



